Medical imaging managers continue to have low expectations for adequate Medicare reimbursement rates.
Medical imaging managers continue to have low expectations for adequate Medicare reimbursement rates, according to the latest data from the Medical Imaging Confidence Index.
When asked what they expect for the third quarter of this year, from July to September, medical imaging managers expressed “very low confidence” in receiving adequate Medicare reimbursement for diagnostic and interventional imaging. This dismal outlook has been holding steady since at least the final quarter of last year.
The Medical Imaging Confidence Index (MICI), co-developed by The MarkeTech Group LLC and AHRA: The Association for Medical Imaging Management, reveals results of an online survey of 149 managers of radiology departments to assess their confidence in market conditions.
In this most recent installment, managers seem to have lost some confidence in whether their departments will grow monthly volume - dipping from “high confidence” to “neutral.” Managers were also neutral about whether they would have capital for imaging equipment and IT needs.
Here are the full results for the third quarter:
Click here to review results from the first half of 2012.
How does it work? Check out the Medical Imaging Confidence Index FAQs.
What do you think?
Medical Imaging Confidence Index (MICI) was co-developed by AHRA:The Association for Medical Imaging Management and The MarkeTech Group, owner of the imagePRO panel, launched in 2008. MICI data rely on the feedback of a statistical cohort of respondents from the imagePRO panel that accurately represent the US market hospital market by bedsize and geographic areas.
Burnout in Radiology: Key Risk Factors and Promising Solutions
June 9th 2025Recognizing the daunting combination of increasing imaging volume and workforce shortages, these authors discuss key risk factors contributing to burnout and moral injury in radiology, and potential solutions to help preserve well-being among radiologists.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.